ARDX

Ardelyx (ARDX)

About Ardelyx (ARDX)

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Details

Daily high
$6.03
Daily low
$5.95
Price at open
$6.03
52 Week High
$10.13
52 Week Low
$3.38
Market cap
1.4B
Dividend yield
0.00%
Volume
1,408
Avg. volume
3.3M
P/E ratio
-21.48

Ardelyx News

Details

Daily high
$6.03
Daily low
$5.95
Price at open
$6.03
52 Week High
$10.13
52 Week Low
$3.38
Market cap
1.4B
Dividend yield
0.00%
Volume
1,408
Avg. volume
3.3M
P/E ratio
-21.48